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Topic Relevance by Time 
Summary 
● Clinical and Translational Science Awards (CTSA) are large federal grants provided to an 
academic institution that support education and infrastructure relevant to translational sci-
ence. 
● CTSA site services, training, and pilot grant funding can benefit researchers at any stage 
of their career, from trainees to faculty.  
● While all CTSA-funded programs offer support for research and training, the focus and 
services offered vary by institution. 
Introduction 
Academic medical centers offer a multitude of opportunities for research. However, it can be dif-
ficult to bridge the gaps between the bench, the bedside, and the marketplace. The National 
Institutes of Health (NIH) have identified this challenge, and offer Clinical and Translational 
Science Awards (CTSAs) to research institutions to help spur innovations. This chapter will 
explore the CTSA concept and how an academic entrepreneur can best tap into the services offered 
by a CTSA, discussing Columbia’s Irving Institute as an example. 
History of Clinical and Translational Science Awards 
The twenty-first century brought a new dawn in the convergence of technology and scientific 
medical discoveries. However, few of these discoveries are translated into improved clinical care, 
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undermining achievement of one of the key goals of the NIH: “foster[ing] fundamental creative 
discoveries, innovative research strategies, and their applications as a basis for ultimately protect-
ing and improving health”  (“Mission and Goals”). 
 
In 2002, Dr. Elias Zerhouni was appointed as director of the NIH during a dynamic time: the 
institute’s budget had been doubled between 1998 and 2003 (E. Zerhouni), yet only 36% of the 
NIH budget was spent on clinical research and training activities (E. A. Zerhouni). Prior to joining 
the NIH, Zehrouni had developed clinically relevant cancer and cardiovascular disease diagnos-
tics. Once at the NIH, he sought to capitalize on the growth in NIH funding to address “critical 
scientific gaps.” He set up discussions between legislators, administration officials, institute 
directors, patient advocates, and scientific leaders to develop “the NIH roadmap,” explaining the 
reorganization as follows: 
 
 The NIH earned its reputation for success because of the vitality of its institutes, 
centers, and offices and because of the diverse ways in which it funds and con-
ducts research—all fostered by decentralization inherent to its organization and 
funding streams. This characteristic serves the agency well and should be 
preserved. However, as science grows more complex, it is also converging on a 
set of unifying principles that link apparently disparate diseases through 
common biological pathways and therapeutic approaches. Today, NIH research 
needs to reflect this new reality. (E. Zerhouni) 
 
In recognition of the “new vision of healthcare,” the NIH sought a new funding model to streamline 
biological research (Zerhouni and Alving). In 2005, this vision was, in part, operationalized 
through a new program to fund institutional centers, the Clinical and Translational Science Award 
(CTSA). The initial request for applications explained the intent of the CTSA program: “to enable 
applicants to engage in innovative and transformative efforts appropriate to their own environment 
that will develop and advance clinical and translational science as a distinct discipline within a 
definable academic home” (Hayward). The new CTSAs were encouraged to consolidate disparate 
efforts in clinical research, such as General Clinical Research Centers, T32 and T12 programs, and 
other resources (Zerhouni and Alving).  
 
The first 12 CTSA grants were awarded in 2006, and by 2008 the program had grown to 38 centers 
in 23 different states, representing all geographic regions of the country. By 2009, over ten thou-
sand researchers, 70% of whom held a doctorate, received funding administered through CTSA 
grants. Subsequently, the National Center for Advancing Translational Science (NCATS) was 
created in 2011 to manage the CTSA program as part of its core mission of accelerating the 
translation of new treatments and cures from the lab to patients. Currently, there are 58 CTSA 
centers (National Center for Advancing Translational Sciences (NCATS) FY 2020 Budget). 
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A key characteristic of research funded by CTSAs is the multidisciplinary and translational nature 
of the projects, with most CTSAs offering a broad range of services (Table 1). Furthermore, the 
national CTSA program is supportive of entrepreneurship, with several CTSA sites emphasizing 
this aspect of clinical and translational research. For example, Duke University’s CTSA has a focus 
on healthcare and entrepreneurship, fostered through an active partnership with the health sector 
management program at the Fuqua School of Business. A similar program at the University of 
California–Davis CTSA encourages faculty entrepreneurism, intellectual property, and business 
development (National Center for Research Resources) (see the chapters “Writing Business Plans 
for a Life Science Startup or Clinical Program”, “Intellectual Property: Ownership and Protection 
in a University Setting” and “Intellectual Property: Commercializing in a University Setting”).  
 
Annual budgets for individual CTSA sites can vary widely, ranging from $4 million to $23 million 
in 2012, for example (Briggs and Austin). The total annual budget for the CTSA program in fiscal 
year 2019 from NCATS was $559 million (“Budget | National Center for Advancing Translational 
Sciences”).  
CTSA Site Organization 
Each CTSA site is located at a U.S.-based academic health science center that has access to an 
affiliated health system, usually inclusive of pediatric healthcare. Many sites are housed within 
medical schools, and several are consortia of medical schools, universities, hospitals, and other 
local educational and research institutions. A hallmark of the CTSA program is that each site is 
given a large degree of flexibility in organizational structure to best meet its needs. Thus, CTSA 
sites vary considerably with regards to the specific research services they offer; these are generally 
funded by the U01 component of the CTSA (Table 1). One CTSA may offer extensive bioinfor-
matics support, while another may choose to focus their funds on genomics. This highlights an 
important point for an academic entrepreneur to keep in mind, especially if they are considering 
transferring from one institution to another: the ability to conduct a research study at one CTSA 
may not necessarily mean that another CTSA can provide similar services (see the chapter “Careers 
in Academia and Industry: Transitions and Challenges”). Also, CTSAs have different cost 
structures for their services, such that one CTSA may have reduced charges for using outpatient 
research suites for certain types of research studies, while another may have higher charges for 
those same studies.  
 
Table 1. Examples of Research Services That May Be Available at a CTSA Site. 
 
Service Example 
Core Facilities ● Translational technologies 
● Laboratory services 
● Embryonic cell lines 
● Nanotechnology 
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● Epigenomics 
Biomedical Informatics ● Behavioral data analysis 
● Geographic coding 
● Proteomics 
● Customized software 
Pilot Funding ● Institutional pilots 
● Trainee and scholar pilot programs 
● Partnerships with industry and not-for-profit programs 
Regulatory Support ● Auditing and compliance measures 
● HIPAA compliance 
● Conflict-of-interest management 
● IRB agreements 
● Protocol development 
Biostatistics Support ● Adaptive trial design 
● Randomization and blinding 
● Statistical modeling and analysis 
Participant and Clinical Interaction 
Resources 
● Cost recovery planning 
● Case report form development 
● Research nurse support 
Community Engagement Resources ● Adult literacy assessment 
● Cultural competency training 
● Public databases 
Source: Adapted from Leshner (Leshner et al.) 
 
In addition to these research services, a core mission of the CTSA program is to support training 
the research workforce. This is generally accomplished through KL2 (for researchers with an MD, 
PhD, or equivalent) and optional TL1 (for predoctoral trainees) awards, which provide access to 
the following components (“Scholar and Research Programs | National Center for Advancing 
Translational Sciences”): 
● Clinical research mentor expertise 
● Access to biomedical research specialized equipment and databases 
● Training through courses, seminars, and workshops 
● Administrative support for research protocols 
● Pilot research project funding 
  
Examples of training programs available through a CTSA include master’s or certificate degrees 
in translational research; these also vary widely by institution. 
 
Each CTSA is also required to establish and maintain an external advisory committee that meets 
annually to discuss structure, progress, and challenges of the program and its research (Leshner et 
al.). Some CTSAs also host internal advisory committees and other advisory and governance struc-
tures, such as executive committees and community advisory boards. 
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The NIH tasked CTSAs with developing a national consortium to identify optimal research 
practices. Originally, this comprised a consortium steering committee staffed by CTSA primary 
investigators. From this main committee, subcommittees were formed around NIH-identified 
priorities like education, informatics, and regulation. At this time, there are an additional three 
main leadership committees (see Table 2). 
 
Table 2: CTSA Committees. 
 
Committee Membership Size Membership Type Purpose 
Consortium Executive 
Committee 
31 total members; 21 
voting members 
PIs, staff, and other Main governing body 
Consortium Steering 
Committee 
175 total members; 85 
voting members 
PIs from each CTSA 
institution, 
representatives from 
NCATS 
Setting strategic goals 
Consortium Child 
Health Oversight 
Committee 
230 total members; 60 
voting members 
PIs, pediatric 
researchers, and staff 
Promoting child health 
and research 
Source: Adapted from Berglund and Tarnatal (Berglund and Tarantal) 
 
How Academic Entrepreneurs Can Access Support from 
Their CTSA Site 
As noted earlier, a CTSA may provide several services that could be of use to an academic entre-
preneur (Table 1). Broadly speaking, these include the following: 
● Educational opportunities: As noted earlier, these are often provided by the KL2 or TL1 
awards, or through dedicated workshops or other training events sponsored by the 
institution’s CTSA award. 
● Research facilities: These may include inpatient or outpatient suites for research study 
visits and specialized lab equipment. They may also provide access to research nurses and 
other trained staff, such as research echocardiography technicians, dieticians, etc., as well 
as core lab services and specimen storage. 
● Specialized expertise: This often includes biostatistics and bioinformatics expertise. 
● Grant funding: Pilot grants and other support are usually available through a competitive 
peer-reviewed process. 
  
Because of the breadth of services offered, accessing these services can be daunting. Since each 
CTSA site has a different name and organization, as a first step, an academic entrepreneur should 
do an internet search for the term “CTSA” and their institution’s name. Typically, there is an option 
to sign up as a member of the CTSA or receive their email announcements. In addition, CTSA 
staff are often very willing to meet with researchers to discuss how the institution’s CTSA can 
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benefit their specific project. One-on-one meetings are very helpful in matching the unique needs 
of a specific research project with beneficial services, training, and pilot grant support. This sup-
port is available to researchers at any stage of their career, from trainee to faculty member.   
Columbia University’s Irving Institute: An Example of a 
CTSA Site 
In 1971, the Columbia Presbyterian Medical Center received a grant from the NIH to establish a 
General Clinical Research Center (GCRC), the predecessor of the CTSA award. This monetary 
support provided for research space, beds, and equipment in early trials on volunteer patients; the 
program was later called the Irving Center for Clinical Research. In 2006, the GCRC funding 
ended, as Columbia was one of the twelve inaugural recipients of a CTSA grant. The initial award 
was $54 million over five years. It allowed the Irving Institute to expand their core resources of 
medical informatics and biostatistics, which has led to the current resource and core offerings: 
● Administrative Core and Evaluation 
● Biomarkers Core Laboratory (BCL) 
● Biomedical Informatics Resource (BMIR) 
● Bionutrition Research Core (BRC) 
● Biostatistics, Epidemiology, and Research Design (BERD) 
● Clinical Research Resource (CRR) 
● Community Engagement Core Resource (CECR) 
● Integrating Special Populations Resource (ISP) 
● Pilot and Collaborative Studies Resource (PCSR) 
● Precision Medicine Resource (PMR) 
● Regulatory Knowledge and Support and Ethics Resource (RKSER) 
● Training and Education (TRANSFORM) 
● Translational Therapeutics Accelerator (TRx) 
● Trial Innovation Network 
 
Characteristically for CTSA centers, the Irving Institute is multidisciplinary and collaborative, in-
corporating multiple institutions: the New York State Psychiatric Institute, the Mailman School of 
Public Health, and the Children’s Hospital of New York. While the focus of the Irving Institute is 
precision medicine, it has also pioneered a translational research accelerator program, the 
Columbia Technology Ventures (see the chapter “Accelerators and Incubators”). At the most 
recent count, in 2017–2018, the Irving Institute CTSA served 380 researchers (including one of 
the authors of this chapter) and engaged in more than 500 research projects.  
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Table 3: Examples of CTSA Educational and Research Grant Support. 
 
Grant Type Target Audience Type of Support Amount of 
Support 
TL1 Pre- and post-doctoral 
researchers 
Salary and educational 
support 
Dependent on PGY 
year; $44,000–
$55,000 and 
benefits for two 
years 
KL2 Early career physician 
researchers 
Salary and educational 
support 
Up to $100,000 per 
year for two years 
Bench-to-Bedside Pilot 
Award 
Assistant professors in 
clinical and basic science 
Research supplies $40,000 for one 
year 
Precision Medicine 
Fellowship 
Clinical fellows with 
doctoral degrees 
Salary $100,000 per year 
for two years 
Irving Scholar Full-time Columbia 
faculty at the rank of 
assistant professor 
Salary support $60,000 per year for 
three years 
 
Academic entrepreneurs at Columbia University can access support from the Irving Institute 
through key funding opportunities organized by career stage (from trainees to faculty). Table 3 
demonstrates examples of the types of services, training, and funding that an Irving Institute grant 
could support. As noted earlier, since each CTSA is different in terms of the services it offers, the 
types of grant support available also will vary. 
 
In addition, even if the Irving Institute does not offer the services needed, an academic entrepreneur 
from Columbia can still access resources at a nearby CTSA since cross-institution collaboration is 
encouraged. 
Conclusion 
The Clinical and Translational Science Award debuted in 2006 as a funding mechanism for aca-
demic medical centers that serves to accelerate the translation of research findings into the world 
of patient care. It accomplishes this mission by centralizing clinical and translational research and 
education in its fifty-eight funded centers and has emerged as a key component in facilitating 
research in the U.S. The CTSA program is very supportive of biomedical entrepreneurship, and 
thus can be an indispensable partner for an academic entrepreneur seeking to develop new 
technology and innovations in patient care. 
7https://repository.upenn.edu/ace/vol1/iss5/5
 
 
CLINICAL AND TRANSLATIONAL SCIENCE AWARDS 
 
 
Resources 
1. A helpful summary of the success of the CTSAs in achieving their purpose and where 
they might be going in the future is provided by the National Academy of Medicine:  
https://www.ncbi.nlm.nih.gov/books/NBK144067/pdf/Bookshelf_NBK144067.pdf. 
2. CTSA program hubs: https://ncats.nih.gov/ctsa/about/hubs. 
3. Types of funded activities under the NCATS CTSA program: 
https://ncats.nih.gov/files/ctsa-funding-information.pdf. 
4. Resources for career development: https://ncats.nih.gov/ctsa/about/training. 
5. NIH REPORT Tutorials: https://report.nih.gov/tutorial/index.aspx. 
6. NIH CTSA in Action: https://ncats.nih.gov/ctsa/action. 
7. NIH Matchmaker: https://projectreporter.nih.gov/reporter_matchmaker.cfm. 
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